Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells.

Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells. Abstract Text:

    shujuan jiangShujuan Jiang,sean c dowdySean C Dowdy,xue w mengXue W Meng,zhaoyu wangZhaoyu Wang,monica b jonesMonica B Jones,karl c podratzKarl C Podratz,shi-wen jiangShi-Wen Jiang,

    OBJECTIVE: To characterize the molecular pathways involved in apoptosis following administration of histone deacetylase inhibitors to Type I and II endometrial cancer cells. METHODS: Ark2, Ishikawa, and AN3 cell lines representing both Type I and II endometrial cancers were treated with various concentrations of oxamflatin and HDAC inhibitor-1. Cell apoptosis was determined by flow cytometry, nuclear staining, Western blotting, and mitochondrial membrane potential assays. RESULTS: Compared to controls, there was a 95% reduction in the growth of Ark2 cells following administration of histone deacetylase inhibitors and this response was dose-dependent. These agents also caused profound morphologic changes and loss of mitochondrial membrane potentials consistent with the induction of apoptosis. Cleavage of PARP, caspase-9, and caspase-8 was detected, confirming the activation of apoptotic cascades in endometrial carcinoma cells. This effect was present in both serous and endometrioid cell types. CONCLUSION: Our results suggest that oxamflatin and HDAC inhibitor-1 have potent cytotoxicity in endometrial cancer cells by inducing cell apoptosis. Histone deacetylase inhibitors are promising agents for the treatment of both Type I and II endometrial carcinoma.

    Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells. Publishing Authors By Initials

    s jiangS Jiang,sc dowdySC Dowdy,xw mengXW Meng,z wangZ Wang,mb jonesMB Jones,kc podratzKC Podratz,sw jiangSW Jiang,

    For similar organic chemicals: amines: hydroxylamines: hydroxamic acids research abstracts see: organic chemicals: amines: hydroxylamines: hydroxamic acids research

    PUBMED ID PMID:

    MEDLINE DATE:

    Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Gynecologic oncology

    VOLUME: 105

    Page Numbers: 493-500

    Journal Abbreviation:

    ISSN: 0090-8258

    DAY: 15

    MONTH: 02

    YEAR: 2007

    Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 365304

    Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells. Keywords Mesh Terms:

    KEYWORDS: Hydroxamic Acids

    MESH TERMS: pharmacology

    Chemical & Substance for Abstract: Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells. Information

    Substance Name: Histone Deacetylases

    Registry Number: EC 3.5.1.-

    Grant and Affiliation Information for Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells.

    AFFILIATION: Shandong Provincial Hospital, Jinan, P.R. China.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NICHD

    GRANT: R01 HD41577

    ACRONYM: HD

    MEDLINETA: Gynecol Oncol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News